Dr. Joseph Zenga, MD

Dr. Zenga practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Zenga's NPI, 1790049799, was assigned on June 25, 2012. Dr. Zenga graduated from Washington University School of Medicine in 2012. Dr. Zenga holds Wisconsin license 68800.

Dr. Zenga's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Zenga's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Zenga is also affiliated with Aurora St. Luke's Medical Center. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Zenga to 1 more hospital and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zenga practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Zenga's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Zenga is licensed in Wisconsin.

CMS data shows 103 Medicare services from Dr. Zenga across 3 procedure codes in 2024, for 88 Medicare patients. Medicare paid $11,626 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Dr. Zenga in 2024. The largest group is 65 to 74, with 40 patients. 73% of them have high blood pressure, and 66% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zenga's median patient age at 70, with 38% women.

In 2024, Dr. Zenga wrote 62 Medicare Part D claims for 39 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $134 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Zenga for performance year 2024, reported as part of a group. Dr. Zenga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of melanoma (skin cancer) excision by Dr. Zenga, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 93 papers to Dr. Zenga, published from 2013 to 2025. 2021 was the busiest year, with 14. The most frequent topics are Head and Neck Neoplasms, Plastic Surgery Procedures and Carcinoma, Squamous Cell. Dr. Zenga has published most often in Oral Oncol. Dr. Zenga's most frequent co-authors are Patrik Pipkorn, MD, Ryan Scott Jackson, MD and Evan Michael Graboyes, MD.

Dmand AI links Dr. Zenga to 2 clinical trials. Conditions studied include Head and Neck Neoplasms, Oropharyngeal Neoplasms and Pharyngeal Neoplasms.

CMS Open Payments shows 2 general payments to Dr. Zenga from 2 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $120.

Dr. Zenga graduated from Washington University School of Medicine in 2012.